Ado-trastuzumab emtansine and Zoledronic acid
Determining the interaction of Ado-trastuzumab emtansine and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Zoledronic Acid (Bone Health)
- Ado-trastuzumab emtansine-Zoledronic Acid (Zometa)
- Ado-trastuzumab emtansine-Zoledronic Acid Injection
- Ado-trastuzumab emtansine-Zoledronic Acid Injection Concentrate
- Ado-trastuzumab emtansine-Zoledronic acid Intravenous
- Ado-trastuzumab emtansine-Zoledronic Acid IV
- Zoledronic acid-Ado-trastuzumab emtansine Intravenous
- Zoledronic acid-Adox Pak 2/100
- Zoledronic acid-Adoxa
- Zoledronic acid-Adoxa CK
- Zoledronic acid-Adoxa Pak
- Zoledronic acid-Adoxa Pak 1/100